Conversely, inhibition of SGLT1 activity in CF was proposed as a way to aid restoration of fluid volume in the ASL although this could lead to elevation of glucose in the ASL with further consequences for respiratory disease (26). The gene discussed is SLC5A1; the disease is respiratory system disorder.